Osteonecrosis of the Jaw

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-04-11
Clinical Trial Update: Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid [NA]
A clinical trial evaluating genetic predictors of bisphosphonate-related osteonecrosis of the jaw in cancer patients treated with zoledronic…